Eupraxia Pharmaceuticals News and Activities

View the org chart displaying its 20 main executives

Most searched biographies at Eupraxia Pharmaceuticals

• James Helliwell, Director and Chief Executive Officer
• Michael Wilmink, Director
• Paul Geyer, Director

Popular executive movements at Eupraxia Pharmaceuticals

• Jeymi Tambiah has joined the company as Chief Medical Officer  (posted on May 4 2026).
• Mark Kowalski, Chief Medical Officer, is retiring  (posted on May 4 2026).
• Paul Brennan, who was Chief Business Officer, is promoted to Chief Corporate Development Officer  (posted on May 4 2026).

Create your alert
to follow the executive moves at Eupraxia Pharmaceuticals.

Eupraxia Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Eupraxia Pharmaceuticals

Social media about Eupraxia Pharmaceuticals

• Eupraxia Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Eupraxia Pharmaceuticals on LinkedIn, X (Twitter) & YouTube